
zzso zzso for obesity are disappointing, and none has yet shown an effect on morbidity or zzso zzso drug treatments have not been assessed zzso zzso maintenance of weight loss requires long-term patient zzso zzso zzso a gastrointestinal zzso zzso is licensed in Europe for the treatment of zzso in combination with a low-calorie zzso zzso The zzso ratio of zzso could not be estimated from the initial assessment file in zzso There were fears over a possible increase in the risk of breast zzso zzso Few new efficacy data have been obtained zzso zzso trials zzso zzso show that zzso zzso zzso three times a zzso combined with dietary intervention, has a minor supplementary effect on weight loss zzso zzso on zzso zzso A zzso of three of the four available comparative trials lasting two years failed to conclude that zzso prevents the onset of type 2 zzso Likewise, there is no firm evidence that zzso lowers cardiovascular morbidity or zzso zzso zzso frequently has gastrointestinal adverse effects, and case reports of hypertension have been zzso zzso probably interacts with a number of other zzso zzso zzso of nearly 8,000 women for only a few years showed no increase in the zzso of breast cancer on zzso zzso In practice, dietary intervention and risk factor management remain the zzso in the management of zzso zzso is only a minor, optional and temporary aid, although it appears so far to have no serious adverse zzso 

